Ameritas Investment Partners’s Pacira BioSciences PCRX Stock Holding History

Ameritas Investment Partners’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$84.9K	Hold	3,345	–	–	﹤0.01%	1944
2026 Q1	$75.6K	Sell	3,345 -501	-13%	-$11.1K	﹤0.01%	1850
2025 Q4	$99.5K	Hold	3,846	–	–	﹤0.01%	1704
2025 Q3	$99.1K	Sell	3,846 -680	-15%	-$16.7K	﹤0.01%	1701
2025 Q2	$108K	Hold	4,526	–	–	﹤0.01%	1700
2025 Q1	$112K	Hold	4,526	–	–	﹤0.01%	1621
2024 Q4	$85.3K	Hold	4,526	–	–	﹤0.01%	1883
2024 Q3	$68.1K	Hold	4,526	–	–	﹤0.01%	2012
2024 Q2	$129K	Hold	4,526	–	–	﹤0.01%	1567
2024 Q1	$132K	Hold	4,526	–	–	﹤0.01%	1559
2023 Q4	$153K	Hold	4,526	–	–	0.01%	1457
2023 Q3	$139K	Buy	4,526 +764	+20%	+$27.5K	0.01%	1424
2023 Q2	$151K	Buy	3,762 +294	+8%	+$12.2K	0.01%	1321
2023 Q1	$142K	Hold	3,468	–	–	0.01%	1297
2022 Q4	$129K	Hold	3,468	–	–	0.01%	1407
2022 Q3	$184K	Hold	3,468	–	–	0.01%	1103
2022 Q2	$202K	Hold	3,468	–	–	0.01%	1062
2022 Q1	$265K	Hold	3,468	–	–	0.01%	1027
2021 Q4	$209K	Hold	3,468	–	–	0.01%	1212
2021 Q3	$194K	Hold	3,468	–	–	0.01%	1224
2021 Q2	$210K	Hold	3,468	–	–	0.01%	1205
2021 Q1	$243K	Sell	3,468 -172	-5%	-$12.3K	0.01%	1082
2020 Q4	$218K	Hold	3,640	–	–	0.01%	1090
2020 Q3	$219K	Hold	3,640	–	–	0.01%	991
2020 Q2	$191K	Hold	3,640	–	–	0.01%	1044
2020 Q1	$122K	Buy	3,640 +191	+6%	+$7.93K	0.01%	1167
2019 Q4	$156K	Hold	3,449	–	–	0.01%	1245
2019 Q3	$131K	Hold	3,449	–	–	0.01%	1309
2019 Q2	$150K	Hold	3,449	–	–	0.01%	1235
2019 Q1	$131K	Hold	3,449	–	–	0.01%	1302
2018 Q4	$148K	Hold	3,449	–	–	0.01%	1131
2018 Q3	$170K	Hold	3,449	–	–	0.01%	1194
2018 Q2	$111K	Hold	3,449	–	–	0.01%	1485
2018 Q1	$107K	Hold	3,449	–	–	0.01%	1446
2017 Q4	$157K	Hold	3,449	–	–	0.01%	1219
2017 Q3	$131K	Hold	3,449	–	–	0.01%	1296
2017 Q2	$165K	Buy	3,449 +302	+10%	+$14K	0.01%	1157
2017 Q1	$144K	Buy	+3,147	New	+$136K	0.01%	1228
2016 Q1	–	Sell	-2,812	Closed	-$216K	–	1182
2015 Q4	$216K	Buy	+2,812	New	+$159K	0.01%	904
2015 Q2	–	Sell	-3,195	Closed	-$284K	–	1211
2015 Q1	$284K	Hold	3,195	–	–	0.02%	851
2014 Q4	$283K	Hold	3,195	–	–	0.02%	846
2014 Q3	$310K	Hold	3,195	–	–	0.02%	788
2014 Q2	$293K	Buy	+3,195	New	+$243K	0.02%	842

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameritas Investment Partners's PCRX Position: Q2 2026 in Review

Ameritas Investment Partners held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 3,345 shares worth $84.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1944.

Ameritas Investment Partners first reported a position in PCRX in Q2 2014 and has held it in 43 quarters since. The position peaked at $310K in Q3 2014. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Ameritas Investment Partners held 3,345 shares of Pacira BioSciences worth $84.9K as of Q2 2026.
Ameritas Investment Partners left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1944 holding.
Ameritas Investment Partners first reported a position in Pacira BioSciences in Q2 2014 and has held it in 43 quarters since.
Ameritas Investment Partners's Pacira BioSciences position peaked at $310K in Q3 2014.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.